本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 近日，湖南华纳大药厂股份有限公司（以下简称"公司"）全资子公司湖南华纳大药厂手性药物有限公司 （以下简称"手性药物"）收到国家药品监督管理局签发的盐酸异丙肾上腺素、重酒石酸去甲肾上腺素 《化学原料药上市申请批准通知书》（通知书编号：2025YS00924、2025YS00925），并在国家药品监 督管理局药品审评中心（CDE）"原辅包登记信息"平台公示。具体情况如下： 一、原料药登记信息 （一）盐酸异丙肾上腺素 1、化学原料药名称：盐酸异丙肾上腺素 2、登记号：Y20240000173 3、申请事项：境内生产化学原料药上市申请 8、与制剂共同审评审批结果：A （二）重酒石酸去甲肾上腺素 1、化学原料药名称：重酒石酸去甲肾上腺素 2、登记号：Y20240000250 3、申请事项：境内生产化学原料药上市申请 4、包装规格：100g/桶。200g/桶。500g/桶。1kg/桶。2kg/桶。3kg/桶。 5、生产企业：湖南华纳大药厂手性药物有限公司 4、包装规格：0.1kg/桶、0 ...

盐酸异丙肾上腺素注射液和重酒石酸去甲肾上腺素注射液均为临床常见的急救用药，并被多地列入"临 床必需易短缺药品"清单。其中，重酒石酸去甲肾上腺素注射液已被纳入第十批国家集采。 据介绍，华纳药厂化学原料药盐酸异丙肾上腺素、重酒石酸去甲肾上腺素获得《化学原料药上市申请批 准通知书》，表明上述原料药已符合国家相关药品审评技术标准，已批准在国内制剂中使用，将进一步 丰富公司产品线，提升公司核心竞争力。(胡敏) 据华纳药厂(688799.SH)消息，近日，其全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监 督管理局签发的盐酸异丙肾上腺素、重酒石酸去甲肾上腺素《化学原料药上市申请批准通知书》。上述 两款原料药与制剂共同审评审批结果为"A"。 据悉，这是华纳药厂年内获得的第7和第8个原料药批件。至此，公司已有72个原料药品种，其中55个原 料药已转"A"(即已批准在上市制剂使用)。 盐酸异丙肾上腺素是盐酸异丙肾上腺素注射液的原料药。盐酸异丙肾上腺素注射液主要用于治疗心源性 或感染性休克；治疗完全性房室传导阻滞，心搏骤停。重酒石酸去甲肾上腺素是重酒石酸去甲肾上腺素 注射液的原料药。重酒石酸去甲肾上腺素注射液用于某些急性低 ...

证券日报网讯 10月23日晚间，华纳药厂发布公告称，近日，公司全资子公司湖南华纳大药厂手性药物 有限公司收到国家药品监督管理局签发的盐酸异丙肾上腺素、重酒石酸去甲肾上腺素《化学原料药上市 申请批准通知书》，并在国家药品监督管理局药品审评中心（CDE）"原辅包登记信息"平台公示。 （文章来源：证券日报） ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 近日，湖南华纳大药厂股份有限公司（以下简称"公司"）全资子公司湖南 华纳大药厂手性药物有限公司（以下简称"手性药物"）收到国家药品监督管理 局签发的盐酸异丙肾上腺素、重酒石酸去甲肾上腺素《化学原料药上市申请批准 通知书》（通知书编号：2025YS00924、2025YS00925），并在国家药品监督管理 局药品审评中心（CDE）"原辅包登记信息"平台公示。具体情况如下： 证券代码：688799 证券简称：华纳药厂 公告编号：2025-081 湖南华纳大药厂股份有限公司 自愿披露关于子公司原料药获得上市申请批准通知 书的公告 一、原料药登记信息 （一）盐酸异丙肾上腺素 1、化学原料药名称：盐酸异丙肾上腺素 2、登记号：Y20240000173 3、申请事项：境内生产化学原料药上市申请 4、包装规格：0.1kg/桶、0.2kg/桶、0.5kg/桶、1kg/桶、2kg/桶、3kg/桶、5kg/ 桶 5、生产企业：湖南华纳大药厂手性药物有限公司 6、生产地址：湖南省长沙市望城区铜官循 ...

华纳药厂公告，全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监督管理局签发的盐酸异丙 肾上腺素、重酒石酸去甲肾上腺素《化学原料药上市申请批准通知书》。盐酸异丙肾上腺素用于治疗心 源性或感染性休克等，重酒石酸去甲肾上腺素用于控制急性低血压状态下的血压。这将丰富公司产品 线，提升核心竞争力。 ...

Market Overview - As of 14:00, the Shanghai Composite Index is at 3859.80 points, with an increase of 0.52% [1] - The total trading volume of A-shares today is 1,431.28 billion yuan [1] Technical Analysis - A total of 84 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - The stocks with the largest distance between their 5-day and 10-day moving averages include: - Yunnan Zhenye: 5-day MA is -2.45% below the 10-day MA [1] - Qiangli New Materials: 5-day MA is -2.22% below the 10-day MA [1] - Feirongda: 5-day MA is -2.14% below the 10-day MA [1] Individual Stock Performance - Yunnan Zhenye (002428): Today's change is -0.93%, with a 5-day MA of 27.71 yuan and a 10-day MA of 28.41 yuan [1] - Qiangli New Materials (300429): Today's change is +0.53%, with a 5-day MA of 13.95 yuan and a 10-day MA of 14.26 yuan [1] - Feirongda (300602): Today's change is +1.03%, with a 5-day MA of 33.00 yuan and a 10-day MA of 33.72 yuan [1] - Other notable stocks include: - Warner Pharmaceuticals (688799): Today's change is +0.43%, with a 5-day MA of 55.41 yuan [1] - Blue Ying Equipment (300293): Today's change is +0.34%, with a 5-day MA of 24.48 yuan [1] Additional Stock Data - The following stocks also show a downward trend in their 5-day moving averages compared to their 10-day moving averages: - Nanya New Materials (688519): -0.90% change, 5-day MA of 74.18 yuan [1] - Aerospace Morning Light (600501): -2.84% change, 5-day MA of 23.60 yuan [1] - Haichen Pharmaceutical (300584): +1.92% change, 5-day MA of 57.39 yuan [1]

Core Points - The Shanghai Composite Index is at 3866.08 points with a change of 0.69% and total A-share trading volume of 899.506 billion yuan [1] - A total of 81 A-shares have seen their 5-day moving average cross below the 10-day moving average, indicating potential bearish trends [1] Group 1: Stocks with Significant Moving Average Crosses - Yunnan Zhenye (002428) has a 5-day moving average of 27.78 yuan, which is 2.34% lower than its 10-day moving average of 28.44 yuan, with a current price of 26.89 yuan, down 5.46% from the 10-day average [1] - Qiangli New Materials (300429) shows a 5-day moving average of 13.97 yuan, down 2.15% from its 10-day average of 14.27 yuan, with a latest price of 13.38 yuan, down 6.26% [1] - Warner Pharmaceutical (688799) has a 5-day moving average of 55.46 yuan, which is 2.01% lower than its 10-day average of 56.60 yuan, with a current price of 51.91 yuan, down 8.28% [1] Group 2: Additional Stocks with Moving Average Crosses - Feirong Technology (300602) has a 5-day moving average of 33.14 yuan, down 1.93% from its 10-day average of 33.79 yuan, with a latest price of 31.96 yuan, down 5.42% [1] - Construction Industry (002265) shows a 5-day moving average of 29.57 yuan, which is 1.90% lower than its 10-day average of 30.14 yuan, with a current price of 28.38 yuan, down 5.84% [1] - Aerospace Morning Light (600501) has a 5-day moving average of 23.64 yuan, down 1.86% from its 10-day average of 24.09 yuan, with a latest price of 21.78 yuan, down 9.58% [1]

Market Overview - The chemical pharmaceutical sector experienced a decline of 1.24% on October 17, with Warner Pharmaceuticals leading the drop [1] - The Shanghai Composite Index closed at 3839.76, down 1.95%, while the Shenzhen Component Index closed at 12688.94, down 3.04% [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Huabang Health (002004) with a closing price of 5.01, up 10.11% on a trading volume of 1.56 million shares and a transaction value of 777 million [1] - Chenxin Pharmaceutical (603367) closed at 23.27, up 10.02% with a trading volume of 551,200 shares and a transaction value of 1.248 billion [1] - Shutaishen (300204) closed at 39.90, up 6.49% with a transaction value of 2.633 billion [1] - Conversely, significant decliners included: - Huanan Pharmaceutical (688799) with a closing price of 51.48, down 6.26% on a trading volume of 57,100 shares and a transaction value of 26.66 million [2] - Xiangrikui (300111) closed at 6.49, down 5.67% with a trading volume of 3.107 million shares and a transaction value of 2.728 billion [2] - Haichen Pharmaceutical (300584) closed at 55.14, down 5.52% with a transaction value of 463 million [2] Capital Flow - The chemical pharmaceutical sector saw a net outflow of 613 million from institutional investors, while retail investors experienced a net inflow of 639 million [2] - Detailed capital flow for selected stocks showed: - Chenxin Pharmaceutical had a net inflow of 235 million from institutional investors, but a net outflow of 56.53 million from retail investors [3] - Shutaishen recorded a net inflow of 194 million from institutional investors, with a net outflow of 72.52 million from retail investors [3] - Huabang Health had a net inflow of 171 million from institutional investors, but a significant net outflow of 86.11 million from retail investors [3]

Core Insights - The total margin balance of the Sci-Tech Innovation Board reached 251.416 billion yuan on October 16, an increase of 1.305 billion yuan from the previous trading day [1] - The financing balance amounted to 250.519 billion yuan, up by 1.301 billion yuan, while the margin short balance was 0.897 billion yuan, increasing by 0.04 billion yuan [1] Individual Stock Performance - On October 16, 319 stocks on the Sci-Tech Innovation Board experienced net financing inflows, with 23 stocks having net inflows exceeding 30 million yuan [1] - Cambricon Technologies led the net financing inflow with an amount of 250 million yuan, followed by stocks such as Baiwei Storage, Juchen Technology, Kesi Technology, Zhongwei Company, Warner Pharmaceuticals, and Lankai Technology [1]

景顺长城研究精选股票A（000688）成立日期2014年8月12日，最新规模26.06亿。今年以来收益 45.98%，同类排名463/4220；近一年收益54.96%，同类排名372/3857；成立以来收益172.25%。 景顺长城研究精选股票A（000688）基金经理为江山。 截至发稿，江山累计任职时间4年65天，现任基金资产总规模108.11亿元，任职期间最佳基金回报 181.78%， 任职期间最差基金回报-16.09%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 10月15日，华纳药厂涨5.06%，截至发稿，报61.43元/股，成交1.71亿元，换手率2.16%，总市值80.67亿 元。 资料显示，湖南华纳大药厂股份有限公司位于湖南省长沙市岳麓区麓天路28号C6-C7栋，成立日期2001 年4月30日，上市日期2021年7月13日，公司主营业务涉及化学原料药、化学药制剂和中药制剂的研发、 生产与销售。主营业务收入构成为：制剂产品73.19% ...